Ruby H N Nguyen1, Charu Mathur, Erin M Wynings, David A Williams, Bernard L Harlow. 1. 1Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN; and 2Chronic Pain and Fatigue Research Center, Department of Anesthesiology, University of Michigan, Ann Arbor, MI.
Abstract
OBJECTIVE: To determine whether rates of remission differed among women with primary versus secondary vulvodynia. METHODS: Using a community-based observational study based in Minneapolis/St. Paul, 138 clinically confirmed cases of vulvodynia between 18 and 40 years old were classified as primary (vulvar pain starting at the time of sexual debut or first tampon insertion) or secondary (vulvar pain starting after a period of pain-free intercourse) and queried regarding their pain history to determine whether they had ever experienced any vulvar pain-free time (remission) or pain-free time lasting 3 months or longer. RESULTS: Remission prevalence was 26% (9/34) for women in the shortest quartile of duration of vulvar pain (<3.8 y) and 38% (13/34) for the longest quartile of duration (≥13 y). After adjusting for vulvar pain duration, generalized vestibular pain, medical treatment, body mass index, and history of pregnancy, women who had primary vulvodynia were 43% less likely to report remission (95% CI = 0.33-0.99) than women with later onset (secondary cases). The association was strengthened when restricting to only remissions lasting 3 months or longer (adjusted risk ratio = 0.43, 95% CI = 0.22-0.84). Generalized vestibulodynia and obesity also reduced the likelihood of remission. CONCLUSIONS: Our study underscores the heterogeneity of vulvodynia and provides evidence that primary vulvodynia may have a less wavering course and, as such, a potentially different underlying mechanism than that of secondary vulvodynia.
OBJECTIVE: To determine whether rates of remission differed among women with primary versus secondary vulvodynia. METHODS: Using a community-based observational study based in Minneapolis/St. Paul, 138 clinically confirmed cases of vulvodynia between 18 and 40 years old were classified as primary (vulvar pain starting at the time of sexual debut or first tampon insertion) or secondary (vulvar pain starting after a period of pain-free intercourse) and queried regarding their pain history to determine whether they had ever experienced any vulvar pain-free time (remission) or pain-free time lasting 3 months or longer. RESULTS: Remission prevalence was 26% (9/34) for women in the shortest quartile of duration of vulvar pain (<3.8 y) and 38% (13/34) for the longest quartile of duration (≥13 y). After adjusting for vulvar pain duration, generalized vestibular pain, medical treatment, body mass index, and history of pregnancy, women who had primary vulvodynia were 43% less likely to report remission (95% CI = 0.33-0.99) than women with later onset (secondary cases). The association was strengthened when restricting to only remissions lasting 3 months or longer (adjusted risk ratio = 0.43, 95% CI = 0.22-0.84). Generalized vestibulodynia and obesity also reduced the likelihood of remission. CONCLUSIONS: Our study underscores the heterogeneity of vulvodynia and provides evidence that primary vulvodynia may have a less wavering course and, as such, a potentially different underlying mechanism than that of secondary vulvodynia.
Authors: Ruby H N Nguyen; Rachael M Turner; Sarah A Rydell; Richard F Maclehose; Bernard L Harlow Journal: Pain Med Date: 2013-06-06 Impact factor: 3.750
Authors: Gloria A Bachmann; Raymond Rosen; Vivian W Pinn; Wulf H Utian; Charletta Ayers; Rosemary Basson; Yitzchak M Binik; Candace Brown; David C Foster; John M Gibbons; Irwin Goldstein; Alessandra Graziottin; Hope K Haefner; Bernard L Harlow; Susan Kellogg Spadt; Sandra R Leiblum; Robin M Masheb; Barbara D Reed; Jack D Sobel; Christin Veasley; Ursula Wesselmann; Steven S Witkin Journal: J Reprod Med Date: 2006-06 Impact factor: 0.142
Authors: M J Tribó; O Andión; S Ros; M Gilaberte; F Gallardo; A Toll; M Ferrán; A Bulbena; R M Pujol; J E Baños Journal: Dermatology Date: 2008 Impact factor: 5.366
Authors: Bernard L Harlow; Gabriela Vazquez; Richard F MacLehose; Darin J Erickson; J Michael Oakes; Susan J Duval Journal: J Womens Health (Larchmt) Date: 2009-09 Impact factor: 2.681
Authors: Barbara D Reed; Ananda Sen; Sioban D Harlow; Hope K Haefner; Richard H Gracely Journal: J Low Genit Tract Dis Date: 2017-01 Impact factor: 1.925
Authors: Georgine Lamvu; Meryl Alappattu; Kathryn Witzeman; Mark Bishop; Michael Robinson; Andrea Rapkin Journal: J Sex Med Date: 2018-04-07 Impact factor: 3.802
Authors: Judith M Schlaeger; Nobuari Takakura; Hiroyoshi Yajima; Miho Takayama; Alana D Steffen; Elizabeth M Gabzdyl; Robyn A Nisi; Kathleen McGowan Gruber; Jason M Bussell; Diana J Wilkie Journal: Pilot Feasibility Stud Date: 2018-04-13
Authors: Judith M Schlaeger; Crystal L Patil; Alana D Steffen; Heather A Pauls; Keesha L Roach; Patrick D Thornton; Dee Hartmann; William H Kobak; Yingwei Yao; Marie L Suarez; Tonda L Hughes; Diana J Wilkie Journal: Pain Rep Date: 2019-02-22